Rossi Roberto, Gissi Davide B, Gabusi Andrea, Fabbri Viscardo Paolo, Balbi Tiziana, Tarsitano Achille, Morandi Luca
Section of Oral Sciences, Department of Biomedical and Neuromotor Sciences, University of Bologna, 40125 Bologna, Italy.
Department of Biomedical and Neuromotor Sciences, Section of Anatomic Pathology "M. Malpighi", Bellaria Hospital, 40125 Bologna, Italy.
Diagnostics (Basel). 2022 Jan 23;12(2):284. doi: 10.3390/diagnostics12020284.
Analysis of genetic or epigenetic markers from saliva or brushing specimens has been proposed as a diagnostic aid to identify patients at risk of developing oral cancer. However, no reliable non-invasive molecular method for this purpose is commercially available. In the present report, we describe the potential application of a procedure based on a 13-gene DNA methylation analysis using oral brushing samples from a patient affected by oral leukoplakia who developed two metachronous oral carcinomas during the follow-up period. A positive or a negative score was calculated for each brushing sample based on a predefined cut-off value. In this patient, a positive score was detected in the oral leukoplakia diagnosed more than 2 years before the development of oral squamous cell carcinoma and subsequently in clinically healthy mucosa 8 months before the appearance of a secondary tumor. This suggests a potential role of our procedure as an indicator of oral cancer risk.
分析唾液或刷牙样本中的基因或表观遗传标记物已被提议作为一种诊断辅助手段,以识别有患口腔癌风险的患者。然而,目前尚无用于此目的的可靠非侵入性分子方法在市场上销售。在本报告中,我们描述了一种基于13基因DNA甲基化分析的程序的潜在应用,该程序使用来自一名口腔白斑患者的刷牙样本,该患者在随访期间发生了两例异时性口腔癌。根据预先定义的临界值为每个刷牙样本计算阳性或阴性分数。在该患者中,在口腔鳞状细胞癌发生前两年多诊断出的口腔白斑中检测到阳性分数,随后在继发性肿瘤出现前8个月在临床健康的黏膜中也检测到阳性分数。这表明我们的程序作为口腔癌风险指标具有潜在作用。